Crohn’s disease is a chronic inflammatory disorder characterized by transmural involvement of the gastrointestinal tract, leading to a wide array of complications that significantly impact patient management. Among the most critical challenges for radiologists is distinguishing between active inflammation and fibrotic strictures—two conditions that may appear morphologically similar on imaging but require vastly different therapeutic approaches. Accurate differentiation is essential to avoid unnecessary surgery or ineffective medical therapy.
Computed tomography enterography (CTE) and magnetic resonance enterography (MRE) are the primary imaging modalities used to evaluate bowel complications in Crohn’s disease. Both techniques provide high-resolution visualization of the small and large intestine, allowing assessment of mural thickening, luminal narrowing, and associated extraintestinal findings such as abscesses, fistulas, and mesenteric changes. However, MRE offers superior soft-tissue contrast and functional information, making it particularly valuable in characterizing the nature of intestinal lesions.
Active inflammation typically manifests on MRE with several key features: bowel wall thickening exceeding 3 mm, increased signal intensity on T2-weighted images, layered enhancement following intravenous gadolinium administration (involving mucosal and serosal layers), and restricted diffusion on diffusion-weighted imaging (DWI).81-24-3 site These findings reflect edema, cellular infiltration, and hyperemia characteristic of acute inflammation. The presence of pre-stenotic dilatation and skip lesions further supports an inflammatory etiology.
In contrast, fibrotic strictures exhibit distinct imaging characteristics. They appear as focal areas of luminal narrowing without significant upstream dilation, with wall thickening that is often uniform rather than layered. On T2-weighted sequences, fibrotic segments show hypointense signal compared to skeletal muscle, reflecting dense collagen deposition. Post-contrast enhancement is minimal or absent, and DWI typically shows no restriction. These features indicate a chronic, non-inflammatory process driven by excessive extracellular matrix accumulation.
The distinction between inflammatory and fibrotic strictures has direct implications for treatment. Inflammatory strictures respond well to anti-inflammatory agents such as corticosteroids, immunomodulators, and biologics. Fibrotic strictures, however, are resistant to medical therapy and usually require mechanical intervention—including endoscopic balloon dilation or surgical resection—to restore bowel continuity.
Imaging protocols must be carefully tailored to optimize this differentiation. MRE sequences should include axial and coronal T2-weighted fat-suppressed images for detecting wall edema, dynamic contrast-enhanced T1-weighted sequences at multiple time points (45–75 seconds post-injection) to assess enhancement patterns, and DWI with b-values ranging from 0 to 800 s/mm² to evaluate cellular density. Coronal cine bSSFP sequences can also help assess peristalsis, aiding in differentiating under-distended loops from inflamed ones.
CTE remains valuable in acute settings, especially when rapid evaluation is needed. It can identify severe luminal narrowing, pre-stenotic dilatation, and complications like perforation or abscess formation.611168-24-2 medchemexpress However, its ability to differentiate fibrosis from inflammation is limited compared to MRE due to lower soft-tissue contrast and lack of functional sequences.PMID:28613645
A common pitfall in interpretation is mistaking bowel under-distension or spastic contractions for true stenosis. This can be minimized by using antispasmodic agents such as hyoscine N-butylbromide and ensuring adequate oral contrast distension with polyethylene glycol or water. Additionally, fixed luminal narrowing seen across multiple imaging planes—even in the absence of upstream dilation—should raise suspicion for a true stricture.
In complex cases, multimodal imaging may be necessary. For example, a patient with suspected stricture may undergo both CTE and MRE to confirm diagnosis and determine the underlying pathology. In some instances, endoscopy with biopsy may still be required to validate imaging findings, particularly when malignancy is a concern.
In conclusion, accurate identification of bowel complications in Crohn’s disease hinges on a comprehensive understanding of imaging features that differentiate active inflammation from fibrosis. Radiologists play a central role in guiding clinical decisions by providing precise, detailed assessments that inform whether medical or surgical intervention is appropriate. By leveraging the strengths of MRE and CTE, integrating advanced sequences, and applying standardized criteria, imaging becomes not only diagnostic but predictive—ultimately improving long-term outcomes for patients with Crohn’s disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com